A Chinese firm, known as Sinovac, one of the leading COVID-19 vaccine developer contenders, recently revealed results from a peer-reviewed […]
Moderna Inc. (Nasdaq: MRNA), the developer of the messenger RNA-based vaccine candidate known as mRNA-1273, reports that the independent NIH […]
The European Commission approved a contract with BioNTech and Pfizer involving the initial purchase of 200 million doses of the […]
Reports out of Ireland suggest that the first COVID-19 vaccine out of the West could be available in Ireland in […]
PriMed Medical Research has already administered the BNT162b2 COVID-19 vaccine candidate to what is reported in the local press, “hundreds” […]
The COVID-19 vaccine candidate known as BNT162b2 may be getting closer to registration (e.g. approval) as the European Medicines Agency […]
The Cleveland area will be contributing to the battle against COVID-19 as University Hospitals was selected by Pfizer and BioNTech […]
TrialSite recently reported on privately-held Aventiv Research Inc. as the only trial site organization in this part of Central Ohio to […]
A recent study by researchers in the US and Germany of two mRNA-based COVID-19 vaccine candidates found that while they […]
“Project Lightspeed” is coming to University Hospitals Cleveland Medical Center (UH) to conduct the pivotal Phase 2/3 global clinical trial […]
